2013年

by 腫瘍病態学分野
  1. Aoki H, Ogura R, Tsukamoto Y, Okada M, Natsumeda M, Isogawa M, Yoshida S, Fujii Y. Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution. Neurol Med Chir (Tokyo): 53 (11): 797-804, 2013.
  2. Kon T, Natsumeda M, Takahashi H, Taki T, Fujii Y, Yamanaka R. Radiation-induced glioblastoma following radiotherapy for pituitary adenomas: marked response to chemotherapy. J Neurol Neurophysiol, 2013.
  3. Kawaguchi A, Yajima N, Tsuchiya N, Honma J, Sano M, Natsumeda M, Takahashi H, Fujii Y, Kakuma T, Yamanaka R. Gene expression signature-based prognostic risk score in patients with glioblastoma. Cancer Sci 104(9):1205-10, 2013.
  4. Yoshimura J, Natsumeda M, Nishihira Y, Nishiyama K, Saito A, Okamoto K, Takahashi H, Fujii Y. Radiation-induced intracranial osteosarcoma after radiation for acute lymphocytic leukemia associated with Li-Faumeni Syndrome. No Shinkei Geka 41 (6): 499-505, 2013.
  5. Jinguji S, Yoshimura J, Nishiyama K, Aoki H, Nagasaki K, Natsumeda M, Yoneoka Y, Fukuda M, Fujii Y. Factors affecting functional outcomes in long-term survivors of intracranial germinomas: a 20-year experience at a single institution. J Neurosurg Pediatr 11 (4): 454-63, 2013.
  6. Miyahara H, Natsumeda M, Shiga A, Aoki H, Toyoshima Y, Zheng Y, Takeuchi R, Murakami H, Masuda M, Kameyama S, Izumi T, Fujii Y, Takahashi H, Kakita A. Suppressed expression of autophagosomal protein LC3 in cortical tubers of tuberous sclerosis complex. Brain Pathol, 23(3): 254-62, 2013.